Richard Newitter
Stock Analyst at Truist Securities
(4.39)
# 209
Out of 4,814 analysts
354
Total ratings
53.33%
Success rate
14.58%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Maintains: Buy | $90 → $70 | $53.43 | +31.01% | 14 | Apr 11, 2025 | |
| VCEL Vericel | Maintains: Buy | $61 → $51 | $40.93 | +24.60% | 3 | Apr 11, 2025 | |
| TFX Teleflex | Maintains: Hold | $149 → $140 | $129.18 | +8.38% | 37 | Apr 11, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $9.5 → $8 | $6.44 | +24.22% | 14 | Apr 11, 2025 | |
| MDT Medtronic | Maintains: Hold | $93 → $90 | $81.80 | +10.02% | 15 | Apr 11, 2025 | |
| KIDS OrthoPediatrics | Maintains: Hold | $26 → $24 | $20.52 | +16.96% | 10 | Apr 11, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $163 → $140 | $115.68 | +21.02% | 6 | Apr 11, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Hold | $26 → $19 | $15.23 | +24.79% | 18 | Apr 11, 2025 | |
| GMED Globus Medical | Maintains: Hold | $82 → $80 | $69.30 | +15.44% | 26 | Apr 11, 2025 | |
| GKOS Glaukos | Maintains: Buy | $185 → $140 | $88.17 | +58.78% | 4 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $78 → $75 | $69.23 | +8.33% | 18 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $113 | $93.58 | +20.75% | 11 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $666 → $605 | $468.32 | +29.19% | 27 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $127 | $100.62 | +26.22% | 17 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $111 → $145 | $98.63 | +47.01% | 16 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $235 | $144.64 | +62.47% | 24 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $96.17 | +17.50% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $409 → $413 | $339.38 | +21.69% | 19 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $285 | $270.71 | +5.28% | 5 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $21 | $13.45 | +56.13% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $14.23 | +40.60% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $91.38 | -10.26% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $196.94 | +26.94% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $4.21 | +518.31% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $172.22 | +347.10% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $56.95 | +49.25% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $13.77 | +45.24% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $15.18 | +77.92% | 5 | Feb 23, 2021 |
PROCEPT BioRobotics
Apr 11, 2025
Maintains: Buy
Price Target: $90 → $70
Current: $53.43
Upside: +31.01%
Vericel
Apr 11, 2025
Maintains: Buy
Price Target: $61 → $51
Current: $40.93
Upside: +24.60%
Teleflex
Apr 11, 2025
Maintains: Hold
Price Target: $149 → $140
Current: $129.18
Upside: +8.38%
Treace Medical Concepts
Apr 11, 2025
Maintains: Hold
Price Target: $9.5 → $8
Current: $6.44
Upside: +24.22%
Medtronic
Apr 11, 2025
Maintains: Hold
Price Target: $93 → $90
Current: $81.80
Upside: +10.02%
OrthoPediatrics
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $24
Current: $20.52
Upside: +16.96%
Integer Holdings
Apr 11, 2025
Maintains: Buy
Price Target: $163 → $140
Current: $115.68
Upside: +21.02%
Integra LifeSciences Holdings
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $19
Current: $15.23
Upside: +24.79%
Globus Medical
Apr 11, 2025
Maintains: Hold
Price Target: $82 → $80
Current: $69.30
Upside: +15.44%
Glaukos
Apr 11, 2025
Maintains: Buy
Price Target: $185 → $140
Current: $88.17
Upside: +58.78%
Apr 11, 2025
Maintains: Hold
Price Target: $78 → $75
Current: $69.23
Upside: +8.33%
Apr 11, 2025
Maintains: Buy
Price Target: $120 → $113
Current: $93.58
Upside: +20.75%
Mar 17, 2025
Maintains: Buy
Price Target: $666 → $605
Current: $468.32
Upside: +29.19%
Feb 27, 2025
Maintains: Buy
Price Target: $120 → $127
Current: $100.62
Upside: +26.22%
Feb 21, 2025
Maintains: Buy
Price Target: $111 → $145
Current: $98.63
Upside: +47.01%
Feb 11, 2025
Maintains: Buy
Price Target: $250 → $235
Current: $144.64
Upside: +62.47%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $96.17
Upside: +17.50%
Jan 30, 2025
Maintains: Hold
Price Target: $409 → $413
Current: $339.38
Upside: +21.69%
Dec 18, 2024
Maintains: Buy
Price Target: $240 → $285
Current: $270.71
Upside: +5.28%
Jan 31, 2023
Maintains: Buy
Price Target: $17 → $21
Current: $13.45
Upside: +56.13%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $14.23
Upside: +40.60%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $91.38
Upside: -10.26%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $196.94
Upside: +26.94%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $4.21
Upside: +518.31%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $172.22
Upside: +347.10%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $56.95
Upside: +49.25%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $13.77
Upside: +45.24%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $15.18
Upside: +77.92%